HOME
SEARCH
RSS FEED
SUBSCRIBE
The Use of Emetine for the Treatment of SARS-CoV-2 Infection
Case ID:
TAB-3597
Web Published:
12/6/2022
Description:
This technology includes the clinical use of the small compound emetine for the treatment of SARS-CoV-2. Previous work has shown that emetine has antiviral properties against some DNA and RNA viruses. It is thought that the mechanism may involve blocking protein synthesis. Work has shown that emetine has potential antiviral activity in multiple tissues that may make it suitable for the treatment of COVID-19.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/The_Use_of_Emetine_for_the_Treatment _of_SARS-CoV-2_Infection
Category(s):
Infectious Disease
Therapeutics
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Ami Gadhia
Senior Technology and Patent Specialist
NIH Technology Transfer
301-827-7159
ami.gadhia@nih.gov
Inventors:
Mark Henderson
Juan Marugan
Andreas Dulcey Garcia
Xin Hu
Marc Ferrer-Alegre
Noel Southall
Keywords:
Emetine
Infection
SARS-CoV-2
treatment
VLXXXX
WIXXXX
WKXXXX
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum